US firm recalls children's drugs

Company cites poor quality for withdrawing more than 40 drugs in 12 countries.

    The company said corrective actions would be implemented before new manufacturing

    The company, a subsidiary of the Canadian firm Johnson and Johnson, advised consumers who had purchased these recalled products to discontinue their use.

    The statement said the company is "conducting a comprehensive quality assessment across its manufacturing operations".

    It said that the company had identified corrective actions that would be implemented before new manufacturing is initiated at the US plant where the recalled products were made.

    The recall came as UN bodies called for more research and clinical trials to close gaps in the market for children's medicines that cost millions lives in developing countries each year.

    Francisco Blanco, the head of medicines and nutrition division of the UN children's fund (Unicef), said that there was a need for more clinical trials and research into paediatric medicines.

    Unicef and the World Health Organisation published a list of medicines designed for children and said it exposed dangerous shortfalls.

    The Geneva-based WHO said the children's medicine guide, which will be available online, would help doctors and health workers get better access to some of the 240 basic medicines.

    SOURCE: Agencies


    YOU MIGHT ALSO LIKE

    Assad to Putin: Thank you for 'saving our country'

    Assad to Putin: Thank you for 'saving our country'

    Russian and Syrian presidents meet to discuss strategy against 'terrorism' and political settlement options.

    What is behind the covert Israeli-Saudi relations?

    What is behind the covert Israeli-Saudi relations?

    Analysts say that the recent covert ties between Israel and Saudi Arabia are due to a new regional paradigm.

    Is Saudi Arabia becoming a danger to the region?

    Is Saudi Arabia becoming a danger to the region?

    We talk to US Congressman Ro Khanna about power politics and debate Mohammed bin Salman's new strategy for the Kingdom.